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Abstract 
BACKGROUND: The goal of this study was to evaluate prospectively the presence and impact of the gastric 
carcinogen Helicobacter pylori in the upper aerodigestive tract. Previous studies suggested it could represent a risk 
factor for head and neck squamous cell carcinoma. 
 
METHODS: Serology, rapid urease test, and quantitative polymerase chain reaction (qPCR) for H. pylori were 
performed in head and neck cancer patients (N=56) and cancer-free controls (N=90). Comparison between groups 
was done using logistic regression analysis. 
 
RESULTS: Rates of positive serology and rapid urease test did not differ between the two groups in logistic 
regression analysis (P=0.677 and P=0.633, respectively). Birth in a developing country and age above 50 years old 
were predictors of positive serology (P<0.001 and P=0.040, respectively). Using qPCR, no biopsy showed presence 
of H.pylori. 
 
CONCLUSION: This study challenges the concept that H. pylori may be a risk factor for head and neck squamous 
cell carcinoma. 
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Introduction 
Helicobacter pylori is a spiral-shaped gram-negative bacterium discovered by Marshall and Warren in 1984 
(1)
. It is 
recognized as an etiological agent of gastric cancer by the World Health Organisation (WHO) (2) and represents one 
of the most common infections worldwide 
(3)
. The prevalence of H. pylori varies strongly between populations, 
being much higher in developing countries. Proposed risk factors include low socioeconomic status, increasing age, 
tobacco use, and infection of siblings (3). 
 
The dominant infection route still remains controversial, while a human-to-human transmission seems probable 
(3)
. 
H. pylori containing liquids are thought to infect new individuals orally, implying that H. pylori must be transiently 
present in the upper aerodigestive tract (UAT) 
(3)
. The presence and potential impact of H. pylori in the UAT is 
subject to debate (4, 5). H. pylori has not only been associated with inflammatory conditions, which include aphthous 
ulcers (6, 7), chronic pharyngitis (8), and dental plaques (9, 10), but also with malignancy such as head and neck 
squamous cell carcinoma (HNSCC) 
(11-16)
. 
 
We described in a previous retrospective pilot study using conventional polymerase chain reaction (PCR) that H. 
pylori can be found in the UAT of 38% of patients with proven gastric colonization 
(17)
. Willing to validate the 
results of our pilot study, we conducted a prospective study combining serology, rapid urease test, and quantitative 
PCR (qPCR). A positive rapid urease test combined with a positive qPCR would indicate the presence of viable H. 
pylori, which would be confirmed by a positive serology. The primary goals of the study were to assess if H. pylori 
could be found in UAT samples of an unselected cohort of patients and if so, would be found more frequently 
among HNSCC patients. The latter would imply a potential carcinogenic role for H. pylori outside of the stomach. 
 
Patients and Methods 
After local ethics review board approval, we prospectively enrolled inpatients at the Department of Otolaryngology 
– Head and Neck Surgery of the University Hospital Zurich, Switzerland, from March 1
st
 2012 to September 30
th
 
2012. Two groups of patients were included: the Tumor Group (TG) with patients undergoing panendoscopy for 
HNSCC, and the Control Group (CG) with patients undergoing tonsillectomy, thyroidectomy, parotidectomy, or 
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endoscopy for benign disease. All patients received an information form detailing the design and purpose of the 
study. The first author (GBM) was then responsible for discussing and settling any questions with the patients. 
After signing the informed consent form, the patients completed a survey to assess for their country of birth, 
tobacco use, alcohol consumption, and gastro-oesophageal reflux. Tobacco use was defined as a current daily 
consumption of cigars or cigarettes. Alcohol consumption was defined as a daily intake of more than 20 grams of 
ethanol at least five days a week. Gastro-oesophageal reflux was defined as troublesome heartburn occurring two 
days or more every week 
(18)
. Exclusion criteria were age less than 18, history of H. pylori eradication, and previous 
radiation in the head and neck area. 
 
A blood sample was drawn from each patient the day before surgery and sent for serologic examination using 
VIDAS H. pylori Ig6 EIA (BioMérieux, Marcy l’Etoile, France); the test was performed according to the 
manufacturer’s instructions; the results were categorized as positive, negative, or indeterminate. During surgery, a 
mucosal specimen was obtained in the TG from the tumor (T) and from the surrounding healthy appearing tissue. 
The latter is further referred to as peritumoral (P). Peritumoral samples were taken approximately one centimeter 
away from the macroscopic tumor. In the CG, a sample was taken from the tonsillar surface in patients undergoing 
tonsillectomy. In the remainder of the CG, a biopsy was taken from the buccal mucosa. Following the operation, all 
samples were divided into two aliquots. The first part was used to perform a rapid urease test (Prontodry®, 
Medisafe©, Hamburg, Germany) according to the manufacturer’s instructions. The second part was stored in 
Allprotect® Tissue Reagent (Qiagen©, Hombrechtikon, Switzerland) and frozen at -20°C until qPCR was 
performed (Figure 1). 
 
Quantitative polymerase chain reaction (qPCR) 
After genomic DNA isolation according to Secka et al. (19), qPCR was performed with Rotorgene® 6000 
(Qiagen©, Hombrechtikon, Switzerland) with 25ng of each isolate. Dissociation and standard curves for all primers 
were generated. Quality control was carried out as recommended by MIQE Guidelines (20). The reactions were 
carried out in triplicates for H. pylori on the ureA gene according to Schabereiter-Gurtner et al. (77-bp PCR 
product size; forward 5’-CGT GGC AAG CAT GAT CC AT-3’; reverse 5’-GGG TAT GCA CGG TTA CGA GT 
TT-3’) (21). GAPDH was used as endogenous control (216-bp PCR product size; forward 5'-AGG GCC CTG ACA 
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ACT CTT TT; reverse 5'-AGG GGA GAT TCA GTG TGG TG). GAPDH reactions were run in parallel to each 
ureA reaction to exclude PCR inhibition. 
An external positive control was obtained using a stomach biopsy, for which H. pylori culture and 
histopathological staining were positive (courtesy of Ch. Gubler, MD, Clinic of Gastroenterology and Hepatology, 
University Hospital Zurich, Switzerland). Amplification occurring after threshold cycle (Ct) 35 and inconsistent 
among technical replicates was considered false positive(22). The genomic DNA isolation and qPCR were 
performed by Microsynth©, Balgach, Switzerland, who were blinded on study group allocation and preliminary 
results. 
 
Statistical analysis 
For dichotomous variables, the two-sided chi-square test was used to compare proportions and phi-coefficient for 
correlations. For discrete variables showing normal distribution, means and standard deviations (SD) are given. 
Alternatively, median, first quartile (Q25), and third quartile (Q75) are indicated. For comparison of means, the t-
test was used. Odds ratio (OR) and 95% confidence interval (95%CI) were calculated according to the Mantel-
Haenzel method. A multivariate binary logistic regression model was used to compare the study groups after 
adjusting for significant variables. A parsimonious model was obtained by backwards elimination of irrelevant 
variables. For serology, analyses were always made twice, once assuming indeterminate cases to be positive, once 
to be negative. If not specified otherwise, the results of the alternate assumption did not differ significantly and are 
shown for the positive assumption. 
An a priori power analysis was conducted with a power value of 80% and two-sided confidence level of 0.95. 
According to the available literature 
(23)
, we assumed a prevalence of approximately 30% in the TG and 10% in the 
CG, with a 2:3 ratio between TG and CG, and obtained a sample size of 50 and 75, respectively. 
Statistical analyses were performed using SPSS® 21.0.0 software (IBM©, Armonk, NY, US) with the help of a 
biostatistician (see acknowledgements). 
 
Results 
In total, 146 subjects were included in the study. Baseline demographic data for the TG and CG are summarized in 
Table 1. A positive ELISA reaction from the blood sample was considered as positive serology. A mucosal 
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fragment eliciting a color change was considered a positive rapid urease test. For qPCR, amplification had to occur 
in all three technical replicates and before Ct=35 to be considered positive (for details see Patients and Methods). 
Rapid urease test and qPCR results for T and P biopsy did not differ notably (data not shown). Results from 
serology, rapid urease test, and qPCR were available for 133, 96, and 101 subjects, respectively. In univariate 
analysis, positive serology and rapid urease test did not differ significantly between the TG and the CG (Table 2). 
For qPCR, none of the samples were positive. Specifically, none of them showed amplification for H. pylori 
specific gene ureA, while the endogenous positive control for GAPDH and the external positive control were 
clearly positive at mean threshold cycle (Ct) of 22.3 (SD 1.79) and mean Ct of 28.5 (SD 0.04), respectively. 
Using a logistic regression model controlling for potential confounding variables, no difference were seen for 
positive serology and positive rapid urease test between the two groups (P=0.677 and P=0.633, respectively). The 
variable “birth in a developing country” showed a highly significant relation with positive serology (P<0.001) in 
both univariate and multivariate analysis. Age above 50 years old also showed to be independent predictor of 
positive serology in multivariate analysis. The other variables – gender, smoking, alcohol consumption, and gastro-
oesophageal reflux – were not significantly associated with positive serology (Table 3). A positive rapid urease test 
did not show any significant association with any of the variables (not shown).  
The correlation between serology and rapid urease test was weak and did not reach statistical significance 
(phi=0.177 P=0.10). 
 
Discussion 
In a previous retrospective pilot study using conventional PCR, we found that 38% of patients with proven gastric 
colonization had presence of H. pylori in the upper aerodigestive tract (UAT). An association with malignancy 
could not be detected, nevertheless the study dealt with a small sample of patients 
(17)
. Acknowledging the 
limitations of our pilot study and willing to validate its findings, we conducted this prospective comparative study 
using qPCR, rapid urease test, and serology. 
 
Overall, we found H. pylori serology to be positive in approximately one-third of our patients, which is comparable 
to data from other western countries 
(3)
. Head and neck cancer patients were not more likely to have positive 
serology than controls, in both univariate and logistic regression analysis. This result does not support an 
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association of H. pylori with HNSCC and is consistent with other serologic studies 
(24-26)
. Two studies however 
reported H. pylori positive serology to be more frequent among head and neck cancer patients. Both of them 
compared cancer-free controls to laryngeal or hypopharyngeal cancer patients (11, 12). The first study reported that H. 
pylori positive serology was associated with an odds ratio almost four times greater than smoking in head and neck 
cancer patients, suggesting unassessed confounding (11). A potential confounder omitted in their multivariate 
regression analysis was increasing age, which is considered a risk factor for positive serology (3) and showed 
uneven distribution between the study groups (P=0.05) 
(11)
. The second study did not perform multivariate analysis, 
and used the chi-square method although of limited sample size. Both factors render the interpretation of their 
results difficult (12, 27). In our study, the only demographic variables significantly associated with a positive serology 
were birth in a developing country and increasing age, which is in accordance with epidemiologic data 
(3)
. 
 
Rapid urease test was frequently positive in our study. However, the correlation between positive urease test and 
positive serology was weak. This is presumably due to the urease activity of bacteria other than H. pylori residing 
in the UAT, leading to non-specific positive rapid urease test (4). Previous studies also reported low specificity of 
this test for extragastric samples 
(28)
. Therefore, rapid urease test results from the UAT should be interpreted as 
“indicative of viable H. pylori” only if good concordance with serology and/or PCR can be observed. 
 
Since H. pylori PCR can yield high false positive rates when performed on extragastric samples 
(21, 29)
, major 
attention was dedicated to the design of the qPCR experiment. We chose to use a validated qPCR protocol for 
extragastric samples, as described by Schabereiter-Gurtner et al. (21). This protocol is highly specific as the target 
gene - ureA - was shown to have 100% homology with H. pylori genome only. It is also very sensitive since it can 
amplify bacterial DNA until 4 fg of DNA (4x10
-15
g), which is equivalent to approximately 2.2 microorganisms 
(21)
. 
Using this method, we failed to show ureA amplification in any of our test samples. This strongly suggests that H. 
pylori was not present in the UAT biopsy samples at the time of the biopsy. In the literature, reported PCR 
detection rates for H. pylori in the UAT range from 0% (5, 30) to 100% (16) in adults, with most studies situated 
between these two extremes (13-17, 31). Many factors may be responsible for this discrepancy: firstly, the targeted 
genes and primers used to detect H. pylori vary widely. It was shown that some commonly used primers may not 
be fully specific, as they show complementarity with genomes of bacterial species other than H. pylori (21). 
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Secondly, even though specific PCR amplification proves that H. pylori DNA is present, it does not allow any 
conclusion on the viability of H. pylori. In fact, positive H. pylori culture has very rarely been reported in studies 
testing UAT samples, even if they showed high rates of positive PCR (14, 31). Thirdly, it should be noted that studies 
with high PCR detection rates were mostly conducted in developing countries, where environmental exposure to H. 
pylori is higher (32). Whether higher detection rates could also be explained by catching in-transit bacteria is yet to 
be elucidated.  
 
H. pylori bacteria may also be detected in the UAT due to gastric contamination (33). H. pylori-contaminated gastric 
fluids may reach the UAT in a retrograde fashion and lead to positive PCR results in the UAT. Gastro-oesophageal 
reflux and supine position would presumably encourage this phenomenon 
(33)
. This factor could explain the 
apparent discrepancy with our pilot study, in which we amplified H. pylori DNA by PCR in 38% of the subjects 
testing UAT samples (17). Unlike the present study conducted in a collective of head and neck patients with 
unknown H. pylori infection status, our pilot study only included patients with H. pylori-positive gastritis and 
coincidental UAT biopsy. Our database contained 2,830 H. pylori-positive gastric biopsies, yet only twenty-six 
patients met the inclusion criteria of the pilot study 
(17)
. A larger collective of unselected patients in the present 
study may have resulted in few incidental individuals with active H. pylori gastric infection – and UAT 
contamination – leading to few positive qPCRs. 
 
On a final note, we compared our results to the literature concerning oesophageal carcinoma, for which H. pylori 
infection was shown to be a protective factor (34). The inverse relation between oesophageal cancer and H. pylori is 
thought to result from lower acidic gastric secretion – a consequence of H. pylori infection – and hence diminished 
chronic irritation of the oesophageal mucosa 
(35)
. Since HNSCC shares many common etiological features with 
oesophageal squamous cell carcinoma, a positive relation between H. pylori infection and head and neck cancer 
appears unlikely 
(36)
. Interestingly, the literature assessing the role of H. pylori in oesophageal cancer does not 
imply the presence of H. pylori in the oesophagus but investigates the remote effect of gastric H. pylori infection on 
the oesophageal mucosa (34). Even in the assumption that H. pylori may be present in the UAT, it is questionable 
whether H. pylori can survive long enough outside the stomach to significantly impact carcinogenesis. Chronic 
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inflammation in the stomach, a significant pathway leading to gastric cancer 
(37)
, was shown to correlate 
consistently with bacterial loads of H. pylori 
(38)
. 
 
In summary, our study provides evidence that H. pylori is not found frequently in the upper aerodigestive tract of a 
non-selected western population of head and neck cancer patients. Furthermore, we did not find head and neck 
cancer patients to show more likely H. pylori positive serology than cancer-free controls. Finally, rapid urease test 
showed non-specific results and should not be used alone for assessing extragastric samples. Although we do not 
believe that H. pylori is a major risk factor for HNSCC, further studies considering patients without history of 
nicotine consumption, alcohol use and negative human papilloma virus status could be of interest, particularly in 
populations from developing countries. 
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Figure 1: Overview of enrollment process and study design  
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Tables 
 
Table 1: Summary of patients’ baseline characteristics   
 
 
 Tumor Group TG 
(N=56) 
Control Group CG 
(N=90) 
All Patients  
(N=146) 
TG vs. CG* 
Variable  Number of patients (% for each study group)  
Gender 
- Female 
- Male 
 
  
12 (21.4) 
44 (78.6) 
 
45 (50.0) 
45 (50.0) 
 
57 (39.0) 
89 (61.0) 
 
P<0.05 
Age
  
- Median [Q25-Q75]
 †
 
 
  
63 [55-69] 
 
37 [25-59] 
 
55 [31-66] 
 
P<0.05 
Country Of Birth
 
- High-income 
- Developing 
 
  
51 (89.3) 
6 (10.7) 
 
70 (77.8) 
20 (22.2) 
 
120 (82.2) 
26 (17.8) 
 
P=0.12 
Tobacco Use 
- Yes 
- No 
 
  
33 (58.9) 
23 (41.1) 
 
43 (47.8) 
57 (52.2) 
 
76 (52.1) 
70 (47.9) 
 
P=0.17 
Alcohol 
- Yes 
- No 
 
  
44 (78.6) 
12 (21.4) 
 
19 (21.1) 
71 (78.9) 
 
63 (43.2) 
83 (56.8) 
 
P<0.05 
Gastro-oesophageal Reflux 
- Yes 
- No 
 
  
7 (12.5) 
49 (87.5) 
 
7 (7.8) 
83 (92.2) 
 
14 (9.6) 
132 (90.4) 
 
P=0.39 
HNSCC Anatomical Site 
- Oral 
- Oropharynx 
- Larynx 
- Hypopharynx 
 
  
8 (14.3) 
29 (51.8) 
14 (25.0) 
5 (8.9) 
 
 
 
  
Type Of Intervention 
- Tonsillectomy 
- Parotidectomy 
- Thyroidectomy 
- Endoscopy for Benign Disease 
 
   
36 (40) 
10 (11.1) 
30 (33.3) 
14 (15.6) 
  
*: Chi-square test. P value for null hypothesis. †: first quartile (Q25) and third quartile (Q75). 
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Table 2: Main results by study group and comparison in univariate analysis 
 Tumor Group TG Control Group CG All subjects TG vs. CG* 
Method of detection Number of patients (% for each study group)  
Serology
† 
- Positive 
- Indeterminate 
- Negative 
 
 
18 (34.6) 
3 (5.8) 
31 (59.6) 
 
26 (32.1) 
5 (8.2) 
50 (61.7) 
 
44 (33.1) 
8 (5.4) 
81 (60.9) 
 
P=0.807 
Rapid urease test
‡ 
- Positive 
- Negative 
 
 
16 (43.2) 
21 (56.8) 
 
16 (26.2) 
45 (73.8) 
 
32 (32.7) 
66 (67.3) 
 
P=0.264 
 
Quantitative PCR
§ 
 
0 0 0  
*: Chi-square test. P value for null hypothesis. 
†: N= 133 [52+81]; ‡: N= 96 [35+61]; §: N=101 [38+63]; (N= total number of subjects for each 
method of detection. The numbers in brackets indicate the number of subjects for the TG and CG, 
respectively). 
 
 
 
Table 3: Logistic regression model for positive serology 
 Unadjusted model
*
  Adjusted model
†
 
Variable OR 95%CI P value  OR 95%CI P value 
Gender 
- Female vs. Male 
 
 
1.06 
 
0.52-2.18 
 
0.869 
  
 
 
 
 
 
Age 
- ≥50 years vs. <50 years 
 
 
1.71 
 
0.82-3.57 
 
0.152 
  
2.76 
 
1.05-7.25 
 
0.040 
Country of birth 
- Developing vs. high-income 
 
 
6.61 
 
2.41-18.15 
 
<0.001 
  
8.00 
 
2.67-23.9 
 
<0.001 
Tobacco use 
- Yes vs. No 
 
 
1.59 
 
0.78-3.22 
 
0.197 
  
1.39 
 
0.64-3.01 
 
0.402 
Alcohol consumption 
- Yes vs. No 
 
 
1.22 
 
0.60-2.44 
 
0.582 
  
 
 
 
 
 
Gastro-oesophageal Reflux 
- Yes vs. No 
 
 
2.51 
 
0.67-9.37 
 
0.171 
  
1.99 
 
0.48-8.31 
 
0.342 
Study group 
- Tumor vs. Control 
 
 
1.09 
 
0.54-2.23 
 
0.807 
  
0.82 
 
0.33-2.02 
 
0.677 
*: Unadjusted odds ratio according to Mantel-Haenzel method 
†: Model adjusted for age, country of birth, tobacco use, and gastro-oesophageal reflux. 
OR: odds ratio. 95%CI: 95% confidence interval. P value for null hypothesis. 
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